ARTICLE

FindCenter AddIcon

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

By Maureen Meehan — 2017

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Read on hightimes.com

FindCenter Post-Image

LSD May Cure Some Addicts

Psychedelic drugs are making a quiet comeback, as a smattering of recent studies have demonstrated their medicinal potential. The latest finding suggests it is time to revisit LSD as a treatment for addiction.

Article
Ian Chant
2012
FindCenter AddIcon
FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

Article
Neuroscience News
2022
FindCenter AddIcon
FindCenter Post-Image

Scientists Show How LSD Blows Open the Doors of Perception

The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.

Article
Ben Turner
2021
FindCenter AddIcon
FindCenter Post-Image

An Introduction to Naturopathy and Functional Medicine

Naturopathic Medicine and Functional Medicine have many similarities as well as many differences. Both systems focus on an individualized, patient-centered approach, identify and address underlying causes of disease and symptoms, and use targeted therapeutic interventions.

Article
Carl Hangee-Bauer, ND, LAc
2022
FindCenter AddIcon
FindCenter Post-Image

An Introduction to Psilocybin

With the advent of the psychedelic renaissance occurring currently, many people have become curious about one of the most famous hallucinogens: psilocybin mushrooms. Read on to discover the most important information about these fascinating fungi.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

It’s Time to Start Studying the Downside of Psychedelics

Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.

Article
Shayla Love
2022
FindCenter AddIcon
FindCenter Post-Image

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon
FindCenter Post-Image

For Protesters, Trauma Lingers Long After the Marching Ends

Instead of relying on systems that have consistently failed the most vulnerable in the protest community, Mullan encourages a shift toward community-based care.

Article
Julia Dupuis
2021
FindCenter AddIcon
FindCenter Post-Image

What Is Post-Traumatic Growth?

Traumatic experiences don’t always have to result in long-term negative consequences. Research proves that exponential growth can actually result from traumatic events instead.

Article
David Smith
2017
FindCenter AddIcon
FindCenter Post-Image

Former Therapist: VA Is Hurting Mental Health Care for Combat Veterans at Its Vet Centers

A former VA therapist says productivity pressure on counselors who treat veterans for mental health issues like PTSD is hurting the quality of care.

Article
Courtney Kube and Rich Gardella
2019
FindCenter AddIcon

EXPLORE TOPIC

MDMA